Canada markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.3400-0.0050 (-1.45%)
At close: 09:30AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 47.16M
Enterprise Value 40.71M
Trailing P/E 9.40
Forward P/E 17.24
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.03
Price/Book (mrq)1.68
Enterprise Value/Revenue 1.74
Enterprise Value/EBITDA 5.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 316.67%
S&P500 52-Week Change 332.26%
52 Week High 30.4500
52 Week Low 30.2300
50-Day Moving Average 30.3444
200-Day Moving Average 30.3593

Share Statistics

Avg Vol (3 month) 349.65k
Avg Vol (10 day) 335.01k
Shares Outstanding 5136.7M
Implied Shares Outstanding 6136.7M
Float 8115.58M
% Held by Insiders 114.53%
% Held by Institutions 10.43%
Shares Short (Aug 15, 2024) 47.63k
Short Ratio (Aug 15, 2024) 40.13
Short % of Float (Aug 15, 2024) 4N/A
Short % of Shares Outstanding (Aug 15, 2024) 40.01%
Shares Short (prior month Jul 15, 2024) 426.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 02, 1999
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 21.73%
Operating Margin (ttm)3.27%

Management Effectiveness

Return on Assets (ttm)3.82%
Return on Equity (ttm)20.04%

Income Statement

Revenue (ttm)23.36M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)-8.50%
Gross Profit (ttm)N/A
EBITDA 3.17M
Net Income Avi to Common (ttm)5.08M
Diluted EPS (ttm)0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.81M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)6.36M
Total Debt/Equity (mrq)22.68%
Current Ratio (mrq)6.62
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)2.13M
Levered Free Cash Flow (ttm)-1.48M